drugset / Trial / NCT04450355

Effects of Continuous Infusion of Intravenous Nefopam on Postoperative Pain and Opioid Consumption After VATS

NCT04450355

RandomizedParallel-groupDouble-blindTreatment

Summary

This prospective, randomized, double-blinded study is designed to evaluate the postoperative analgesic effect of the continuous infusion of intravenous nefopam in patients undergoing video-assisted thoracic surgery (VATS). We hypothesize that the continuous infusion of intravenous nefopam can significantly reduce postoperative opioid consumption and pain severity in patients with VATS.

Timeline

Start
2020-07-30
Primary completion
2021-08-09
Completion
2021-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 80 mg Intravenous

Indications

No indication recorded.